Loading insider details...
Beta
Latest Form 4 (Aug 25, 2026): Sale of 15,009 ARDX shares, $57.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | ARDELYX, INC. (ARDX) | Sale | 15,009 | $57.9K |
| Jul 17, 2026 | ARDELYX, INC. (ARDX) | Exercise/Conversion | 20,834 | $20.6K |
| Jun 17, 2026 | ARDELYX, INC. (ARDX) | Exercise/Conversion | 20,833 | $20.6K |
| May 22, 2026 | ARDELYX, INC. (ARDX) | Sale | 14,933 | $93.6K |
| May 19, 2026 | ARDELYX, INC. (ARDX) | Exercise/Conversion | 20,833 | $20.6K |
| Apr 27, 2026 | AMICUS THERAPEUTICS, INC. (FOLD) | Disposition to Issuer | 115,857 | $1.68M |
| Apr 17, 2026 | ARDELYX, INC. (ARDX) | Exercise/Conversion | 20,834 | $20.6K |
| Mar 18, 2026 | ARDELYX, INC. (ARDX) | Exercise/Conversion | 20,833 | $20.6K |
| Feb 25, 2026 | ARDELYX, INC. (ARDX) | Exercise/Conversion | 20,833 | $20.6K |
| Feb 24, 2026 | ARDELYX, INC. (ARDX) | Sale | 40,401 | $237.0K |